Rohto Pharmaceutical Co.Ltd. (RPHCF) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Rohto Pharmaceutical Co.L...

PNK: RPHCF · Real-Time Price · USD
20.09
-6.54 (-24.56%)
At close: Jan 24, 2025, 9:00 PM

Rohto Pharmaceutical Cash Flow Statement

Financials in JPY. Fiscal year is April - March.
Fiscal Year Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period Ending Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022
Net Income
9.56B 7.5B 9.09B 4.74B 8.45B 6.2B 6.99B
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
n/a n/a n/a n/a n/a n/a n/a
Other Working Capital
n/a n/a n/a n/a n/a n/a n/a
Other Non-Cash Items
-9.56B -7.5B -9.09B -4.74B -8.45B -6.2B -6.99B
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
n/a n/a n/a n/a n/a n/a n/a
Operating Cash Flow
n/a n/a n/a n/a n/a n/a n/a
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a n/a
Financial Cash Flow
n/a n/a n/a n/a n/a n/a n/a
Net Cash Flow
n/a n/a n/a n/a n/a n/a n/a
Free Cash Flow
n/a n/a n/a n/a n/a n/a n/a